Biomarker Assay Design & Validation Strategy
Design and validate clinical biomarker assays with regulatory compliance
What You Can Do
You can systematically design clinical biomarker assays by defining biomarker specifications, creating detection protocols, planning validation cohorts, and analyzing performance metrics with statistical rigor. This skill guides you through analytical and clinical validation phases, helping you establish acceptance criteria (sensitivity, specificity, ROC-AUC), develop statistical analysis plans, and generate regulatory-compliant documentation for FDA/EMA submission—reducing rework and accelerating the path from discovery to clinical validation.
Features
Define clinical context, intended use, and performance thresholds before assay design
Structure sensitivity, specificity, linearity, and reproducibility studies with acceptance criteria
Size cohorts statistically for adequate positive/negative controls and clinical decision-making
Define primary/secondary endpoints, power calculations, and hypothesis testing strategies
Calculate and interpret ROC curves, PPV/NPV, concordance, and clinical utility indices
Generate compliance-ready protocols, study designs, and submission summaries for FDA/EMA pathways
Design assay workflows for biomarker combinations with interaction analysis
Structure and power studies using archived samples or electronic health records
Example Output
Example 1: Analytical Validation Protocol
- Assay: ALK fusion detection in NSCLC tumors
- Acceptance criteria: ≥95% sensitivity, ≥99% specificity in 50 positive/50 negative samples
- Methods: FISH validation against ddPCR gold standard with 10% discordant panel
- Statistical analysis: Fisher's exact test for sensitivity/specificity; ROC-AUC with 95% CI
Example 2: Clinical Validation Study Design
- Biomarker: 4-protein signature for treatment response prediction
- Sample size: 200 patients (80% power, α=0.05) for primary endpoint of 70% PPV
- Cohort: Retrospective, stratified by disease stage; prospective validation phase planned
- Primary analysis: Logistic regression with biomarker score as predictor; ROC-AUC comparison to standard care
Example 3: Regulatory Submission Summary
- Device: LDT for circulating tumor DNA burden in metastatic colorectal cancer
- Clinical context: Monitoring response to immunotherapy
- Performance data: 94% sensitivity, 96% specificity; 0.91 ROC-AUC in validation cohort
- Submission strategy: 510(k) pathway with two clinical studies supporting analytical and clinical validity
What's Included
- SKILL.md instruction file with core workflow phases and decision trees:
- Biomarker Specification Template: clinical context, intended use statement, performance thresholds
- Analytical Validation Protocol Framework: study designs for sensitivity, specificity, linearity, reproducibility
- Statistical Analysis Plan (SAP) Checklist: primary endpoints, power calculations, analysis populations, hypothesis tests
- Regulatory Documentation Checklist: FDA 510(k), EMA IVD protocols, and clinical evidence summaries
- Performance Metrics Worksheet: ROC curve, PPV/NPV, concordance, and decision curve analysis templates
Who It's For
- Bioinformatics scientists designing clinical biomarker assays and validation studies
- R&D managers transitioning biomarkers from research to clinical development pipelines
- Regulatory affairs specialists preparing biomarker submissions for FDA/EMA approval
- Clinical laboratory directors developing new liquid or tissue biomarker panels
- Biotech/pharma project leaders planning companion diagnostic assay validation programs
Best For
- Designing end-to-end analytical and clinical validation studies for single or multi-marker assays
- Creating statistical analysis plans and power calculations for biomarker cohorts
- Defining acceptance criteria (sensitivity, specificity, ROC-AUC) for assay performance
- Generating regulatory-compliant protocols and documentation for FDA/EMA submissions
- Planning retrospective or prospective validation cohorts from existing samples or health records
You might also like
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-w
You can architect end-to-end bioinformatics analysis pipelines by translating your research question into algorithmic approaches, selecting and optimizing appropriate tools and parameters for your dataset, and validating results against biological expectations. This skill guides you through the complete decision tree from raw data to publication-ready interpretation, helping you avoid parameter overfitting, misinterpreted statistical thresholds, and algorithm selection errors that compromise research validity.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
You can upload or describe product designs and receive a comprehensive analysis of manufacturing feasibility, cost drivers, and prioritized optimization recommendations. The skill identifies design inefficiencies, material waste opportunities, assembly complexity challenges, and supply chain risks—giving you actionable steps to reduce costs and prevent production delays before they happen.
by kody-w
This skill helps you synthesize complex environmental toxicology and fate data into cohesive, regulatory-quality Environmental Assessment narratives. You can organize hazard identification, exposure assessment, and risk characterization frameworks; integrate multi-study ecotoxicity evidence; cross-reference FDA/EMA/ICH M7 guidance; and identify data gaps—all while maintaining scientific rigor and compliance consistency required for NDAs, INDs, and BPCIs.
by kody-w
You can design experiments with appropriate controls, replicate structures, and sample sizes before conducting any bench work. This skill helps you establish clear endpoints, identify confounding variables, select the right statistical tests, and create reproducible data collection protocols—preventing costly failed experiments and increasing publishability.
by kody-w